Bank of America’s MEDIROM Healthcare Technologies MRM Stock Holding History

Bank of America’s Portfolio MRM Stock Details MRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25	Closed	-$75	–	8321
2024 Q3	$75	Hold	25	–	–	﹤0.01%	7766
2024 Q2	$98	Sell	25 -382	-94%	-$2.1K	﹤0.01%	7702
2024 Q1	$2.5K	Buy	407 +382	+1,528%	+$2.27K	﹤0.01%	7097
2023 Q4	$143	Sell	25 -25	-50%	-$126	﹤0.01%	7377
2023 Q3	$289	Buy	+50	New	+$292	﹤0.01%	7368
2021 Q4	–	Sell	-326	Closed	-$3K	–	8472
2021 Q3	$3K	Buy	+326	New	+$2.47K	﹤0.01%	7831

Other funds holding MRM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Bank of America's MRM Position: Q4 2024 in Review

Bank of America sold out of MEDIROM Healthcare Technologies (MRM) in Q4 2024, closing a stake of 25 shares — an estimated $75 sold.

Bank of America first reported a position in MRM in Q3 2021 and held it in 6 quarters. The position peaked at $3K in Q3 2021. 5 funds tracked by Wall St. Rank hold MRM as of Q4 2024.

Bank of America reported no remaining MEDIROM Healthcare Technologies position as of Q4 2024 after selling out during the quarter.
Bank of America sold 25 MEDIROM Healthcare Technologies shares in Q4 2024, an estimated $75.
Bank of America first reported a position in MEDIROM Healthcare Technologies in Q3 2021 and held it in 6 quarters.
Bank of America's MEDIROM Healthcare Technologies position peaked at $3K in Q3 2021.
5 funds tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q4 2024.

Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.